Skip to main content

A Newly Characterized Potentially Probiotic Strain, Lactobacillus brevis MK05, and the Toxicity Effects of its Secretory Proteins Against MCF-7 Breast Cancer Cells

  • 2021-03-09
  • Probiotics and Antimicrobial Proteins 13(4)
    • Mona Pourbaferani
    • Sima Modiri
    • A. Norouzy
    • H. Maleki
    • Mohadeseh Heidari
    • L. Alidoust
    • Venus Derakhshan
    • H. Zahiri
    • K. A. Noghabi

Abstract

Among seven strains of lactic acid bacteria (LAB) isolated from traditional dairy products, a Lactobacillus strain was identified through 16S rRNA gene sequencing and tentatively designated as Lactobacillus brevis MK05. This strain demonstrated the highest probiotic potential through biochemical analysis, including acid and bile salt resistance, as well as antibacterial activity. The collected cell-free supernatant (CFC) of L. brevis MK05 culture, compared with MRS broth with pH equal to the pH for CFC, revealed antimicrobial activity against Escherichia coli (ATCC 25922) and Staphylococcus aureus subsp. aureus (ATCC 25923), possibly due to the presence of antibacterial metabolites other than organic acids. This strain was, therefore, selected to assess the biological activity of its partially purified secretory proteins against MCF-7 cancer cells and normal fibroblast cells via the MTT assay. The partially purified cell-secreted proteins of this strain (hereafter referred to as Lb-PPSPs) showed a time and dose-dependent anti-cancer and apoptosis induction function. There was a remarkable decline in the survival rate of MCF-7 cells at doses equal to and higher than 0.5 mg/mL after 48 h. The changes in expression of the three genes involved in the apoptosis pathway (BAX, BCL-2, and BCL2L11) in MCF-7 cells treated with the Lb-PPSPs confirm its cytotoxic activity and apoptosis induction.

Keywords: Antibacterial; Apoptosis; Lactobacillus brevis; MCF-7 breast cancer cells; Probiotics.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus brevisIncreased Apoptosis in Cancer CellsBeneficial
Large
Lactobacillus brevisReduced MCF-7 Breast Cancer Cell ViabilityBeneficial
Large
Lactobacillus brevis SBC8803Reduced Cancer Cell ViabilityBeneficial
Large
Lactobacillus brevis UALbr-02Increased Antibacterial ActivityBeneficial
Moderate
Lactobacillus brevis UALbr-02Increased ApoptosisBeneficial
Large
Lactobacillus brevis UALbr-02Reduced Cancer ActivityBeneficial
Moderate
Lactobacillus brevis VPro 18Increased Antibacterial ActivityBeneficial
Moderate
Lactobacillus brevis VPro 18Reduced Cancer ActivityBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.